Five Nutrients, One Mechanism — The Science Behind This Neuroprotective Combination
Every ingredient in this formulation targets a distinct and documented pathway in nerve damage — and each one's effectiveness is amplified when the others are present. This is not a multivitamin constructed for general wellness; it is a clinically reasoned five-way combination built around the neuroscience of peripheral nerve protection and repair.
Methylcobalamin 1500mcg is the neurologically active coenzyme form of Vitamin B12 — the form that participates directly in myelin sheath synthesis without requiring hepatic conversion, unlike cyanocobalamin which must first be processed by the liver before becoming biologically usable. At 1500mcg, this dose goes substantially beyond standard supplementation to provide the elevated B12 substrate required for myelin sheath repair in patients with established neuropathy, B12 deficiency anaemia, or diabetic nerve damage. Methylcobalamin also supports methionine synthesis and reduces circulating homocysteine — a neurotoxic amino acid that accelerates nerve fibre degeneration when levels are chronically elevated.
Alpha Lipoic Acid 100mg is a naturally occurring, mitochondrially active antioxidant uniquely capable of functioning in both aqueous and lipid environments — a property that allows it to neutralise free radicals throughout the nerve cell, including in the lipid-rich myelin membrane where other antioxidants cannot penetrate. In diabetic neuropathy specifically, oxidative stress generated by chronic hyperglycaemia is a primary driver of nerve fibre loss. Alpha lipoic acid directly counters this by scavenging reactive oxygen species, regenerating other antioxidants including vitamins C and E, and improving glucose uptake in peripheral nerve tissue — slowing the progression of diabetic nerve damage from within the metabolic pathway that causes it.
Pyridoxine Hydrochloride 3mg (Vitamin B6) is essential for the enzymatic conversion of homocysteine to cystathionine — the transsulphuration step that, when impaired by B6 insufficiency, allows homocysteine to accumulate to neurotoxic levels. B6 is also the coenzyme for over 100 amino acid metabolic reactions and is indispensable for synthesis of neurotransmitters including serotonin, dopamine, and GABA — biochemicals that regulate mood, sleep, and pain perception in neuropathic conditions.
Folic Acid 1.5mg completes the homocysteine-lowering triad alongside methylcobalamin and pyridoxine. Folate donates the methyl group in the methionine cycle that converts homocysteine back to methionine — a reaction that requires methylcobalamin as cofactor. Without adequate folate, this conversion stalls regardless of B12 status, and homocysteine rises. Folic acid also drives DNA synthesis and red blood cell formation, and during pregnancy provides the neural tube protection that makes it a foundational prenatal supplement.
Vitamin D3 1000IU rounds out the formulation with its increasingly recognised role in neurological health beyond calcium regulation. Vitamin D receptors are expressed throughout the central and peripheral nervous systems — in neurons, Schwann cells, and glial tissue. Vitamin D insufficiency, affecting an estimated 70–80% of the Indian population due to indoor occupational patterns and dietary gaps, is independently associated with increased neuropathic pain severity, impaired nerve conduction velocity, and higher rates of depression in neuropathy patients. At 1000IU, this formulation provides a clinically meaningful D3 dose without risk of toxicity.
Methylcobalamin Alpha Lipoic Acid Tablet Uses — Who This Formulation Is Prescribed For
The methylcobalamin alpha lipoic acid tablet uses span a defined cluster of neuropathic and nutritional deficiency conditions where multi-pathway supplementation outperforms single-agent approaches.
Diabetic Peripheral Neuropathy is the single largest indication driving prescription volume for this combination in India. With over 50% of Indian diabetics estimated to develop peripheral neuropathy over their lifetime, and with oxidative stress, B12 depletion from metformin use, and homocysteine elevation all contributing simultaneously, the five-nutrient combination addresses the actual clinical complexity of the condition — not just one marker of it. Methylcobalamin folic acid and pyridoxine HCl tablets lower homocysteine while alpha lipoic acid reduces oxidative nerve damage and vitamin D3 supports nerve conduction, providing comprehensive neuroprotective cover.
Peripheral Neuropathy from B12 Deficiency — Whether from dietary insufficiency, malabsorption, prolonged metformin therapy, or ageing-related reduced intrinsic factor production, B12 deficiency neuropathy produces a characteristic pattern of numbness, tingling, and weakness in a stocking-glove distribution. Methylcobalamin 1500mcg at this dose directly replenishes the depleted coenzyme, supporting myelin sheath rebuilding over a course of months.
Numbness and Tingling in Hands and Feet — One of the most common neurological complaints seen across general medicine, endocrinology, and orthopaedic outpatient settings in India, peripheral paraesthesia from multiple causes responds to this combination — with methylcobalamin addressing axonal repair, ALA reducing oxidative sensitisation of nerve endings, and pyridoxine supporting neurotransmitter regulation in affected sensory pathways.
Neuropathic Pain — Burning, shooting, or electric-shock pain caused by damaged peripheral nerves in diabetic, post-herpetic, or idiopathic neuropathy is increasingly managed with nutritional nerve support alongside pharmacological pain therapy. The combination's multi-target approach — myelin repair, antioxidant protection, homocysteine control, and D3-mediated neurological support — provides a complementary foundation for long-term neuroprotection.
Vitamin D Deficiency with Neurological Manifestations — Fatigue, muscle weakness, bone pain, and mood disturbances from vitamin D insufficiency compound neuropathic symptoms and worsen patient quality of life. Including D3 1000IU in this formulation addresses the deficiency that most neurologists routinely find co-existing with neuropathy in Indian patients.
Pregnancy and Pre-Conception Neural Support — The folic acid 1.5mg + methylcobalamin combination provides neural tube protection and haematological support for women of childbearing age. Pyridoxine additionally addresses nausea in early pregnancy while supporting fetal neurological development.
Carpal Tunnel Syndrome and Repetitive Strain Neuropathy — Pyridoxine B6 supplementation has been studied for carpal tunnel syndrome, and the combination of B6, B12, and folate supports overall nerve health in patients with repetitive-motion occupational neuropathies.
Third Party & Contract Manufacturing for Neuroprotective Nutraceutical Tablets
The neurology nutraceutical segment in India is growing faster than most pharmaceutical categories — driven by rising diabetes prevalence, expanding neurologist prescribing, and increasing patient awareness of nutritional nerve support. Brands entering or expanding in this space need a manufacturing partner who understands the formulation complexity of multi-active nutraceutical tablets, not just a commodity tablet producer.
Delwis Healthcare is a WHO-GMP certified third party pharmaceutical manufacturer and CDMO partner for methylcobalamin alpha lipoic acid folic acid pyridoxine hydrochloride and vitamin D3 tablets — offering complete outsourced manufacturing for neurology brands, nutraceutical companies, and pharmaceutical exporters.
Third Party Manufacturing — Your brand, our GMP-compliant manufacturing. Complete production of this five-active combination tablet in 10×10 Alu-Alu blister packs under your registered brand name — including API sourcing, tablet compression, film coating, packaging, and labeling.
Contract Manufacturing (CDMO) — Full development and manufacturing partnership from API qualification and formulation development through process validation, stability studies, and commercial batch production with complete regulatory documentation for your target market.
Private Label Manufacturing — Custom brand name, carton design, blister foil branding, and labeling format tailored to your neurology or nutraceutical segment positioning.
Bulk Supply — Consistent, documentation-backed commercial batch supply for institutional procurement, hospital formularies, and export distribution with batch-specific COA and full quality records.
Manufacturing Capability — Nutraceutical Tablet Production at Delwis Healthcare
Manufacturing a five-active nutraceutical tablet containing both water-soluble B vitamins and lipid-soluble vitamin D3 alongside alpha lipoic acid demands specific formulation science. ALA is particularly challenging — it oxidises rapidly, is photosensitive, and interacts with excipients in ways that reduce potency if blending and coating parameters are not tightly controlled.
Delwis Healthcare's WHO-GMP, ISO 9001, and ISO 14001 certified facility in Ahmedabad is equipped for this complexity:
- Inert-atmosphere blending for oxidation-sensitive APIs including alpha lipoic acid
- Validated sequential loading protocols for lipid-soluble and water-soluble active combinations
- Film coating with light and moisture barrier polymers protecting ALA and methylcobalamin stability
- Controlled-humidity tablet compression suites preventing hygroscopic API degradation
- Automated Alu-Alu blister filling and sealing with 100% seal integrity verification
- Electronic batch records and QMS documentation aligned with WHO-GMP audit requirements
Quality Testing — Batch Release Standards for This Five-Active Combination Tablet
Releasing a five-component nutraceutical tablet requires validating each active independently and confirming no inter-ingredient degradation has occurred during manufacture or storage. Every batch clears the following before leaving our facility:
- HPLC Assay (×5) — Individual quantification of methylcobalamin, alpha lipoic acid, vitamin D3, pyridoxine HCl, and folic acid against certified reference standards
- ALA Stability Testing — Dedicated oxidative degradation check confirming alpha lipoic acid potency retention within specification
- Dissolution Profile — Release testing across all five actives confirming bioavailability-aligned dissolution per USP/IP specifications
- Content Uniformity — Per-tablet dose consistency across stratified batch sampling
- Microbial Limit Testing — Microbiological safety compliance for oral nutraceutical tablets
- Hardness, Friability & Disintegration — Physical tablet quality parameters per pharmacopoeial limits
- Stability Studies — Real-time and accelerated ICH-compliant data supporting 24-month shelf life claim on Alu-Alu packaging
Why Nutraceutical Brands Choose Delwis Healthcare for This Neuroprotective Tablet
Neurology supplement brands and nutraceutical companies manufacturing this combination at Delwis Healthcare cite these differentiating capabilities:
- WHO-GMP & ISO 9001/14001 Certified — Regulatory credentials supporting CDSCO domestic registration and export market submissions
- ALA Handling Expertise — Inert-atmosphere processing and oxidation-control protocols specifically for alpha lipoic acid stability
- Five-Active Dose Accuracy — Validated blending and in-process testing confirming correct potency of all five nutrients per tablet
- Alu-Alu Blister Standard — Complete light and moisture barrier packaging protecting photosensitive ALA and methylcobalamin across the full shelf life
- Nutraceutical + Pharma Hybrid Capability — Experience manufacturing both nutraceutical and pharmaceutical tablet combinations under unified GMP compliance
- Full CDMO Support — Formulation development through stability studies to regulatory dossier preparation
- Flexible MOQ — Pilot validation batches through to large-volume commercial runs
- Export Documentation Ready — COA, stability reports, and manufacturing credentials for international market submissions
Methylcobalamin Alpha Lipoic Acid Tablet — Clinical and Manufacturing Questions Answered
Q1: What is methylcobalamin alpha lipoic acid tablet used for?
This five-nutrient combination is used for diabetic peripheral neuropathy, B12 deficiency neuropathy, numbness and tingling in the extremities, neuropathic pain, vitamin D deficiency with neurological involvement, and homocysteine-related nerve damage. It is also prescribed for pregnancy nutritional support owing to the folic acid and methylcobalamin content.
Q2: What is the difference between methylcobalamin and cyanocobalamin?
Methylcobalamin is the biologically active coenzyme form of B12 — it participates directly in myelin synthesis and methionine metabolism without requiring conversion. Cyanocobalamin, the synthetic form found in most low-cost supplements, must first be processed in the liver to become metabolically useful. For patients with neuropathy or nerve damage requiring rapid tissue-level B12 activity, methylcobalamin at 1500mcg is the clinically preferred form.
Q3: How does alpha lipoic acid help in diabetic neuropathy?
Chronic hyperglycaemia generates reactive oxygen species that damage peripheral nerve fibres, disrupt blood-nerve barrier function, and impair axonal transport. Alpha lipoic acid neutralises these free radicals in both water-soluble and lipid-soluble nerve compartments, improves glucose uptake in nerve tissue, regenerates endogenous antioxidants, and reduces the oxidative burden at the cellular level — addressing the primary metabolic driver of diabetic nerve damage rather than just managing symptoms.
Q4: Why is vitamin D3 included in a nerve health supplement?
Vitamin D receptors are present throughout the nervous system including peripheral neurons and Schwann cells. Deficiency — which affects the majority of Indian adults — independently worsens neuropathic pain, reduces nerve conduction velocity, and is associated with higher rates of depression in neuropathy patients. The 1000IU dose in this formulation corrects insufficiency at a clinically effective level without toxicity risk.
Q5: Can this tablet be taken daily and for how long?
Yes, this combination is designed for daily oral use. For diabetic neuropathy and peripheral neuropathy, a minimum 3–6 month course is typically prescribed with clinical reassessment — nerve repair occurs slowly and supplementation must be sustained for measurable functional improvement. Long-term maintenance therapy is used in patients with chronic neuropathic conditions or persistent B12 deficiency. All treatment decisions should be under physician guidance.
Q6: Should this tablet be taken before or after food?
Taking this tablet after meals is recommended. Food improves the absorption of fat-soluble components including vitamin D3 and alpha lipoic acid, and reduces the gastric discomfort that occasionally occurs with alpha lipoic acid on an empty stomach.
Q7: What are the side effects of methylcobalamin alpha lipoic acid tablets?
Side effects are generally mild and transient. The most commonly reported are mild nausea, stomach discomfort, or loose stools — particularly with alpha lipoic acid on an empty stomach. Rarely, patients may experience mild headache or skin rash. At the doses in this formulation, all five actives have well-established safety profiles for daily supplementation. Patients with known hypersensitivity to any component should consult their physician.
Q8: Do you offer third party manufacturing for this neuroprotective tablet?
Yes. Delwis Healthcare manufactures methylcobalamin 1500mcg + alpha lipoic acid 100mg + vitamin D3 1000IU + pyridoxine hydrochloride 3mg + folic acid 1.5mg tablets in 10×10 Alu-Alu blister packs for third party and contract manufacturing clients — with custom brand labeling, carton design, and full WHO-GMP compliant batch documentation for Indian and export markets. Contact info@delwishealthcare.com with your requirements.
